Insilico Medicine partners with Human Longevity unit to co-develop AI foundation model for longevity science

• Insilico Medicine Cayman Topco entered a multi-million-dollar AI co-development collaboration with Human Life Foundation Models, a Human Longevity-backed company.
• Partnership targets an industry-first large-scale AI foundation model focused on longevity science, aiming to decode aging biology and support predictive healthcare.
• Insilico will provide multimodal model engineering and training benchmarks via its MMAI Gym framework; HLFM will contribute de-identified multi-omic clinical datasets.
• Companies expect the model to be commercially available for early detection of age-related diseases, health risk prediction, and AI-driven therapeutic discovery.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605260941PR_NEWS_USPR_____CN67655) on May 26, 2026, and is solely responsible for the information contained therein.